Upgrade to SI Premium - Free Trial

Zimmer Biomet (ZBH) PT Lowered to $146 at Needham & Company

April 27, 2018 6:28 AM
Needham & Company lowered its price target on Zimmer Biomet (NYSE: ZBH) to $146.00 (from $155.00) while maintaining a Strong ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles